Becker's Healthcare January 2, 2025
Elizabeth Gregerson

Cancer screening declined 39% globally during the COVID-19 pandemic, according to a study published Jan. 2 in Nature.

For the study, international researchers reviewed 245 academic articles from 46 countries to analyze the scale of COVID-19’s disruption on cancer care.

Here are four notes from their analysis:

  1. In addition to the 39% decline in cancer screening, diagnostic procedures declined by 24% and cancer diagnoses declined by 23% compared to prepandemic levels.
  2. Cancer treatment declined by 28% overall, with a 15% decline in radiotherapy treatment and a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID, Survey / Study, Trends
Related Articles:
The U.S. Government and the World Health Organization - 2
Moderna gets $590M from US government for bird flu vaccine
CDC: Flu activity remains high, COVID-19 increasing while RSV peaks
As H5N1 Is Detected In San Francisco, A Panel Discusses Next Steps
Donald Trump’s first steps on healthcare: Inaugural remarks, leaving the WHO, and more

Share This Article